NEW YORK, Sept. 7, 2016 /PRNewswire/ -- Rosen Law
Firm, a global investor rights law firm, reminds purchasers of
American Renal Associates Holdings, Inc. securities (NYSE: ARA):
(1) pursuant and/or traceable to American Renal's Initial Public
Offering on or about April 21, 2016
(the "IPO"); and/or (2) from April 21,
2016 through August 18, 2016
of the important October 31, 2016
lead plaintiff deadline in the class action. The lawsuit seeks to
recover damages for American Renal investors under the federal
securities laws.
To join the American Renal class action, go to the firm's
website at http://www.rosenlegal.com/cases-946.html or call
Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or
email pkim@rosenlegal.com or kchan@rosenlegal.com for information
on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A
CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU
RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO
NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, throughout the Class Period defendants
issued false and misleading statements to investors and/or failed
to disclose that: (1) American Renal was engaged in a fraudulent
scheme to steer patients away from qualified-for Medicare and
Medicaid plans into more expensive Affordable Care Act plans to
obtain greater reimbursement for American Renal's dialysis
services; (2) the foregoing scheme was in violation of federal and
state laws; and (3) as a result, American Renal's public statements
were materially false and misleading at all relevant times. When
the true details entered the market, the lawsuit claims that
investors suffered damages.
Follow us for updates on LinkedIn:
https://www.linkedin.com/company/the-rosen-law-firm or on Twitter:
https://twitter.com/rosen_firm.
A class action lawsuit has already been filed. If you wish to
serve as lead plaintiff, you must move the Court no later than
October 31, 2016. A lead plaintiff is
a representative party acting on behalf of other class members in
directing the litigation. If you wish to join the litigation, go to
the firm's website at http://www.rosenlegal.com/cases-946.html or
to discuss your rights or interests regarding this class action,
please contact Phillip Kim, Esq. or
Kevin Chan, Esq. of Rosen Law Firm
toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com or
kchan@rosenlegal.com.
Rosen Law Firm represents investors throughout the globe,
concentrating its practice in securities class actions and
shareholder derivative litigation.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
Kevin Chan, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 34th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
kchan@rosenlegal.com
www.rosenlegal.com
Logo - http://photos.prnewswire.com/prnh/20160907/405060LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/investor-alert-rosen-law-firm-reminds-american-renal-associates-holdings-inc-investors-of-important-deadline-in-class-action---ara-300324011.html
SOURCE Rosen Law Firm, P.A.